Brukinsa 160 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9MU9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $83,601
Award facts
- Contract value 100% obligated
- $83,601.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $83,601.40 to Amerisourcebergen Drug Corp for the supply of Brukinsa 160 mg tablets (60-count) with a firm fixed price structure. The contract, which became effective on January 26, 2026, is scheduled for completion by February 17, 2026, and represents a non-set-aside, competitively awarded procurement. The work will be performed in Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its corporate headquarters. This delivery order is issued under Amerisourcebergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026, which serves as the comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems. The company has demonstrated consistent capability in fulfilling federal procurement requirements across a diverse portfolio of therapeutic domains, ranging from specialty medications to vaccines and medical devices. The DLA's broader pharmaceutical supply chain strategy includes planning for next-generation Prime Vendor Global Program contracts with potential multiple awards across separate regions, positioning Amerisourcebergen to serve Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and comprehensive contract vehicles.
Quick answers
Who was awarded contract SPE2DR26F9MU9?
SPE2DR26F9MU9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F9MU9 worth?
The government has obligated $83,601 on SPE2DR26F9MU9.
Is contract SPE2DR26F9MU9 an order under another contract?
Yes. SPE2DR26F9MU9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MU9 competed?
The extent of competition for SPE2DR26F9MU9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award